Response Biomedical Corp. develops, manufactures and markets the RAMP system, a rapid diagnostics platform that delivers lab quality performance for efficient patient management in acute care settings. RAMP is a global leader in comprehensive acute care testing with a wide range of markers available including Troponin I, CK-MB, NT-proBNP, D-dimer and Procalcitonin. For effective and efficient patient care, RAMP tests aid in the diagnosis of Acute Myocardial Infarction, Heart Failure and Sepsis.